glp-1 receptor agonists in pediatric and adolescent obesity Role of glucagon-like peptide-1 metabolic dysfunction associated steatotic liver disease Management of Childhood Obesity

[80] were able to show how both topical and systemic liraglutide administration prevented retinal degeneration in db/db mice

Biomed Pharmacother

10.1038/s41598-021-88612-x 45 KimM.PlattM

Physiology and pathophysiology of incretins in the kidney

The images or other third party material in this article are included in the articles Creative Commons licence, unless indicated otherwise in a credit line to the material

In the SURMOUNT-1 trial, tirzepatide produced dose-dependent weight reductions, with average losses approaching or exceeding ~20% at higher doses in adults with obesity who did not have diabetes, numbers that markedly exceed historical pharmacotherapy benchmarks